Skip to main content
SpringerLink
Log in

Post-transplant Immune Function and the Development of Lymphoma

  • Chapter
  • First Online:
Neoplastic Hematopathology

Part of the book series: Contemporary Hematology ((CH))

  • 2158 Accesses

Abstract/Scope of Chapter

Both hematopoietic stem cell transplantation and solid organ transplantation are associated with short-term and long-term immune deficits that result in an increased risk of disseminated infection and malignancy. Here, we discuss these risk factors and the time-course for the development of post-transplant lymphoproliferative disorders in each transplant type.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Auletta JJ, Lazaru HM. Immune restoration following hematopoietic stem cell transplantation: an evolving target. Bone Marrow Transplant 2005;35:835-857.

    Article  PubMed  CAS  Google Scholar 

  2. Vilchez RA, Jauregui MP, Hsi ED, Novoa-Takara L, Chang C. Simian virus 40 in posttransplant lymphoproliferative disorders. Hum Pathol 2006;37:1130-36

    Google Scholar 

  3. Ghelani D, Saliba R, de Lima M. Secondary malignancies after hematopoietic stem cell transplantation. Crit Rev Oncol Hematol 2005;56:115-26.

    Article  PubMed  Google Scholar 

  4. Swerdlow SH, Webber SA, Chadburn A, Ferry JA. Post-transplant lymphoproliferative disorders In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, et al., eds. WHO classification of tumours of hematopoietic and lymphoid tissues. Lyon, France: IARC, 2008:343-49

    Google Scholar 

  5. Villard J. Immunity after organ transplantation. Swiss Med Wkly 2006;136:71-7.

    PubMed  CAS  Google Scholar 

  6. Dolcetti R. B lymphomas and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders. Autoimmun Rev 2007;7:96-101.

    Article  PubMed  CAS  Google Scholar 

  7. Kauffman HM, Cherikh WS, McBride MA, et al. Transplant recipients with a history of malignancy: risk of recurrent and de novo cancers. Transplant Rev 2005;19:55-64.

    Article  Google Scholar 

  8. Chapman JR, Sheril AGR, Disney APS. Recurrence of cancer after renal transplantation. Transplantation Proc 2001;33:1830-1.

    Article  CAS  Google Scholar 

  9. Kauffman HM. Malignancies in organ transplant recipients. J Surg Oncol 2006;94:431-3.

    Article  PubMed  Google Scholar 

  10. Martin DC, Rubini M, Rosen VJ. Cadaveric renal homotransplantations with inadvertent transplantation of carcinoma. JAMA 1965;192:752-4.

    Article  Google Scholar 

  11. Wilson RE, Penn I. Fate of tumors transplanted with a renal allograft. Transplant Proc 1975;7: 327-31.

    PubMed  CAS  Google Scholar 

  12. Gottschalk S, Rooney GM, Heslop HE. Post-transplant lymphoproliferative disorders. Ann Rev Med 2005;56:29-44.

    Article  Google Scholar 

  13. Yin CC, Jones D. Molecular approaches towards characterization, monitoring and targeting of viral-associated hematological malignancies. Expert Rev Mol Diagn 2006;6(6):831-41.

    Article  PubMed  CAS  Google Scholar 

  14. Chadburn A, Cesarman E, Knowles DM. Molecular pathology of posttransplantation lymphoproliferative disorders. Semin Diagn Pathol 1997;14(1):15-26.

    PubMed  CAS  Google Scholar 

  15. Swerdlow SH. T-cell and NK-cell post-transplantation lymphoproliferative disorders. Am J Clin Pathol 2007;127:887-895.

    Article  PubMed  Google Scholar 

  16. Rowlings PA, Curtis RE, Passweg PA, et al. Increased incidence of Hodgkin’s disease after allogeneic bone marrow transplantation. J Clin Oncol 1999;17:3122-7.

    PubMed  CAS  Google Scholar 

  17. Said JW. Immunodeficiency-related Hodgkin lymphoma and its mimics. Adv Anat Pathol 2007;14(3):189-94.

    Article  PubMed  Google Scholar 

  18. Starzl TE, Nalesnik MA, Porter KA, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine-steroid therapy. Lancet 1984;1:583-7.

    Article  PubMed  CAS  Google Scholar 

  19. Cohen J, Bollard CM, Khanna R, Pittaluga S. Current understanding of the role of Epstein-Barr virus in lymphomagenesis and therapeutic approaches to EBV-associated lymphomas. Leuk Lymphoma 2008;49(S1):27-34.

    Google Scholar 

  20. Taylor AL, Marcus R, Bradley JA. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol 2005;56:155-67.

    Google Scholar 

  21. Rooney CM, Smith CA, Ng CY, et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogenic transplant recipients. Blood 1998;92:1549-55.

    PubMed  CAS  Google Scholar 

  22. Haque T, Wilkie GM, Taylor C, et al. Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogenic cytotoxic T cells. Lancet 2002;360:436-42.

    Google Scholar 

  23. Knowles DM, Cesarman A, Chadburn A, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttranplantation lymphoproliferative disorders. Blood 1995;85:552-65.

    Google Scholar 

  24. Chadburn A, Chen JM, Hsu D, et al. The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant. Cancer 1998;82:1978-87.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anatomic Pathology, National Institutes of Health, Houston, MD, USA

    Deqin Ma

  2. Department of Hematopathology, M. D. Anderson Cancer Center, The University of Texas, Houston, TX, USA

    Dan Jones

Authors
  1. Deqin Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dan Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Deqin Ma .

Editor information

Editors and Affiliations

  1. M.D. Anderson Cancer Center, The University of Texas, Holcombe Blvd. 1515 , Houston, 77030, U.S.A.

    Dan Jones

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Ma, D., Jones, D. (2010). Post-transplant Immune Function and the Development of Lymphoma. In: Jones, D. (eds) Neoplastic Hematopathology. Contemporary Hematology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-384-8_30

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-384-8_30

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-383-1

  • Online ISBN: 978-1-60761-384-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation